Top 5 Spirometry Tips for COPD Diagnosis and Management
Here are five valuable tips to achieve reliable, accurate results when performing spirometry tests to diagnose or manage COPD.
Here are five valuable tips to achieve reliable, accurate results when performing spirometry tests to diagnose or manage COPD.
The US Preventive Services Task Force recommends people without signs or symptoms of COPD should not be screened because it does not improve overall health.
Asthma FeNO testing will be available in more US primary care settings as the result of a new national distribution model for Circassia Inc's NIOX Vero FeNO testing device.
The US FDA is warning people not to use the E25Bio COVID-19 Direct Antigen Rapid Test (DART), according to an agency alert.
Read MoreThe Siemens Healthineers CliniTest Rapid COVID-19 Antigen Self-Test is now available in the United States. The test received FDA authorization in January 2022.
Read MoreA single blood sample from a critically ill COVID-19 patient can be analyzed by a machine learning model which uses blood plasma proteins to predict survival, weeks before the outcome.
Read MoreThe US FDA updated the medical device shortage list to include all blood specimen collection tubes to the testing supplies and equipment – specimen collection category.
Read MorePathogenomix Inc’s Patho-Seq is designed for the rapid detection and identification of bacteria for a broad list of clinical conditions and sample types, including sepsis from whole blood samples and bacterial meningitis from CSF.
Read MoreMild symptoms, poor knowledge of nearby testing sites, and certain demographic factors have been identified as barriers to COVID-19 testing.
Read MoreBronchoscopy plays a role in both diagnosis and treatment of lung disease and recent advances in the procedure have greatly enhanced the usefulness of the fiberoptic bronchoscope.
Read MoreThe FDA has warned consumers to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories COVID-19 IgG/IgM Antibody Test.
Read MoreThe earliest batch of COVID-19 tests distributed by the US CDC exhibited false positive reactivity of negative controls due to flaws in assay design and contamination in one of the assay components, according to a CDC internal investigation.
Read MoreWerfen has received FDA 510(k) clearance for its GEM Hemochron 100 whole blood hemostasis system, which will be commercialized in the US in early 2022.
Read MoreThe successful implementation of transcutaneous CO2 equipment at Hershey Medical Center’s Level IV NICU demonstrates that the technology has evolved to accommodate the diagnostic monitoring needs of neonatal care providers and patients, according to this case study by clinicians in the center’s NICU.
Read MoreThe FDA has issued an emergency use authorization for the Acon Laboratories Flowflex COVID-19 Home Test, an over-the-counter COVID-19 antigen test.
Read More